Once - daily amoxicillin versus twice - daily penicillin V in <font color="blue">group_1</font> <font color="blue">A_1</font> <font color="blue">beta_1</font> <font color="blue">-_1</font> <font color="blue">haemolytic_1</font> <font color="blue">streptococcal_1</font> <font color="blue">pharyngitis_1</font> <font color="blue">._1</font> <font color="blue">
<br>
<br>_1</font> BACKGROUND Rheumatic fever is a preventable chronic disease preceded by <font color="blue">group_1</font> <font color="blue">A_1</font> <font color="blue">beta_1</font> <font color="blue">-_1</font> <font color="blue">haemolytic_1</font> <font color="blue">streptococcal_1</font> <font color="blue">(_1</font> <font color="blue">GABHS_1</font> <font color="blue">)_1</font> <font color="blue">pharyngitis_1</font> <font color="blue">._1</font> 
<br> OBJECTIVE To <font color="blue">test_1</font> <font color="blue">the_1</font> <font color="blue">non_1</font> <font color="blue">-_1</font> <font color="blue">inferiority_1</font> of once - daily ( QD ) oral amoxicillin to the recommended twice - daily ( BID ) oral penicillin V in GABHS pharyngitis . 
<br> METHODS This was a randomised non - inferiority trial carried out in a school - based clinic in New Zealand . Children presenting with <font color="blue">GABHS_1</font> <font color="blue">pharyngitis_1</font> were randomised to oral amoxicillin 1500 mg QD ( or 750 mg if bodyweight was < or=30 kg ) or to oral penicillin V 500 mg BID ( or 250 mg if bodyweight was < or=20 kg ) for 10 days . <font color="blue">Observed_1</font> <font color="blue">medication_1</font> <font color="blue">and_1</font> <font color="blue">weekend_1</font> <font color="blue">diary_1</font> <font color="blue">cards_1</font> <font color="blue">were_1</font> <font color="blue">used_1</font> <font color="blue">to_1</font> <font color="blue">monitor_1</font> <font color="blue">adherence_1</font> <font color="blue">._1</font> <font color="blue">
<br>_1</font> <font color="blue">OUTCOME_1</font> <font color="blue">Eradication_2</font> <font color="blue">of_2</font> <font color="blue">GABHS_2</font> <font color="blue">,_2</font> <font color="blue">determined_1</font> <font color="blue">with_1</font> <font color="blue">follow_1</font> <font color="blue">-_1</font> <font color="blue">up_1</font> <font color="blue">throat_1</font> <font color="blue">cultures_1</font> on days 3 - 6 , 12 - 16 and 26 - 36 . GABHS isolates were serotyped to distinguish bacteriological treatment failures ( and relapses ) from new acquisitions . Non - inferiority was defined as an upper 95% confidence limit ( CL ) for the difference in success of eradication in the amoxicillin and penicillin V treatment groups of < or=10% . 
<br> RESULTS 353 children with positive throat swabs for GABHS were randomised to amoxicillin ( n = 177 ) or penicillin V ( n = 176 ) . The upper 95% CL for the differences in positive cultures between the antibiotics was 4.9% at days 3 - 6 , 6.5% at days 12 - 16 and 8.5% at days 26 - 36 . <font color="blue">Treatment_3</font> <font color="blue">failures_3</font> <font color="blue">(_1</font> <font color="blue">including_1</font> <font color="blue">relapses_1</font> <font color="blue">)_1</font> occurred at each visit in 5.8% , 12.7% and 10.7% of amoxicillin recipients and 6.2% , 11.9% and 11.3% of penicillin V recipients , respectively . No significant differences in <font color="blue">resolution_2</font> <font color="blue">of_2</font> <font color="blue">symptoms_2</font> were noted between treatment groups . One case of unsubstantiated <font color="blue">acute_2</font> <font color="blue">rheumatic_2</font> <font color="blue">fever_2</font> occurred after 7 days of amoxicillin . 
<br> CONCLUSION In this adequately powered study , once - daily oral amoxicillin is not inferior to twice - daily penicillin V for the treatment and eradication of <font color="blue">GABHS_1</font> in children with pharyngitis .